Global Chronic Pain Market Size To worth $140.5 billion By 2030 | CAGR of 5.8%

Category: Healthcare

RELEASE DATE Apr 2023
REPORT ID SI1701

A PHP Error was encountered

Severity: Notice

Message: Undefined variable: table

Filename: press/detail.php

Line Number: 118

Backtrace:

File: /home/admin/web/sphericalinsights.com/public_html/application/views/press/detail.php
Line: 118
Function: _error_handler

File: /home/admin/web/sphericalinsights.com/public_html/application/views/layouts/master_header_footer.php
Line: 720
Function: view

File: /home/admin/web/sphericalinsights.com/public_html/application/controllers/Press.php
Line: 89
Function: view

File: /home/admin/web/sphericalinsights.com/public_html/index.php
Line: 295
Function: require_once

Global Chronic Pain Market worth $140.5 billion by 2030

According to a research report published by Spherical Insights & Consulting, the Global Chronic Pain Market Size to grow from USD 69.1 billion in 2021 to USD 140.5 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period.

 

Global Chronic Pain Market

Get more details on this report -

Request Free Sample PDF

Browse key industry insights spread across 200 pages with 105 market data tables and figures & charts from the report on "Global Chronic Pain Market Size, Share, and COVID-19 Impact Analysis By Indication (neuropathic pain, chronic back pain, arthritis pain, migraine, cancer pain, fibromyalgia, Others), By Product (Drugs, Devices), by Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030)". Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/chronic-pain-market

 

Chronic pain results from nerve discomfort that lasts for a few months or a year. However, some people experience chronic pain without ever having been injured. Chronic pain is typically defined as pain that lasts for at least 12 months and is brought on by conditions like cancer, arthritis, or neurogenic pain. Opioid painkillers, nonsteroidal anti-inflammatory drugs, and adjuvant analgesics are a few of the most often used medications to manage chronic pain. However, due to increased awareness of the potential negative effects of continuous use of pain relief medications, such as the danger of side effects and addiction, healthcare providers and patients typically look for alternate pain relief therapy.

 

COVID 19 Impact

Individuals who already have illnesses are more likely to experience stress during the COVID 19 outbreak, which raises the need for medication and medical attention. Hospitals and cancer treatment facilities also experienced significant disruptions in medical diagnostic and screening practises. In addition to this, the pandemic has led to a substantial increase in patient consumption of medications such non-steroidal anti-inflammatory pills and opioids. As a result of the reopening of hospitals and healthcare facilities, which is expanding the chronic pain industry, the market has seen strong growth during the second half of 2020.

 

The global chronic pain industry is heavily driven by the ageing population, which includes an increase in opioid use, chronic medical conditions, over-the-counter medicine demand, and a vast network of retail pharmacies. In addition, the prevalence of chronic diseases like diabetes, cancer, neuropathy, multiple sclerosis, and osteoarthritis is boosting market expansion. According to the World Health Organization (WHO), cancer will cause 10 million deaths worldwide in the year 2020. As chronic illnesses are growing more prevalent today, several treatment techniques including physiotherapy, medications, psychiatric therapy, etc. are also employed to lessen discomfort.

 

The growing acceptance of alternative pain management methods as people become aware of the risks associated with the widespread use of painkillers has a significant impact on the global market for chronic pain.

 

Indication Insights

The neuropathic pain segment is dominating the market over the forecast period

Based on indication, the global chronic pain market is segmented into neuropathic pain, chronic back pain, arthritis pain, migraine, cancer pain, fibromyalgia, and others. Among these, the neuropathic pain segment is dominating the market with the largest market share over the forecast period. Injury to the body affects the somatosensory nerve system, causing chronic pain called neuropathic pain. In 2019, chronic pain was reported to affect approximately 65% of Americans 65 and older.

 

Product Insights

The drug segment holds the largest market share over the forecast period

On the basis of product, the global chronic pain market is segmented into drugs and devices. Among these, the drug segment is dominating the market with the largest market share over the forecast period and is going to continue its dominance over the upcoming years. The simple availability of over-the-counter medications and reasonable prices are credited with the growth. In reality, these medications are capable of treating a variety of symptoms, including migraines, lower back pain, and severe headaches.

 

Regional Insights

North America is dominating the market with the largest market share over the forecast period.

Due to rising hurdles to receiving sufficient care, people suffering from both acute and chronic pain, and North America's domination of the market with the biggest market share, this trend is expected to continue. In the United States, there will be more than 52 million chronic pain patients by 2020.

 

Global Chronic Pain Market

Get more details on this report -

Request Free Sample PDF

The fastest market growth, however, has been seen in Europe as a result of the rise in chronic pain situations, which has led to a significant increase in the sales of opioid medications. Germany, France, Spain, the United Kingdom, and Italy hold a majority of the European chronic pain market.

 

Major vendors in the Global Chronic Pain Market are Eli Lilly and Company, Pfizer Inc., Abbott Laboratories, Medtronic Plc., Boston Scientific Corporation, Novartis AG, Johnson & Johnson, AstraZeneca PLC, Bristol-Myers Squibb Company, Becton. 

 

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies